Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Verrica Pharmaceuticals sell BiotechBee

Verrica Pharmaceuticals
Start price
€4.61
12.08.24 / 60%
Target price
€3.00
29.03.26
Performance (%)
21.53%
End price
€5.60
14.08.24
Summary
This prediction ended on 14.08.24 with a price of €5.60. The prediction closed with a disappointing performance of 21.53%. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Verrica Pharmaceuticals - - -
iShares Core DAX® 3,59 % 3,93 % 15,38 %
iShares Nasdaq 100 5,81 % 5,52 % 41,46 %
iShares Nikkei 225® 4,08 % 8,46 % 48,95 %
iShares S&P 500 4,14 % 4,04 % 31,59 %

According to BiotechBee what are the pros and cons of Verrica Pharmaceuticals for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Verrica Pharmaceuticals diskutieren
Prediction Sell
Perf. (%) 21.53%
Target price 3.000
Change
Ends at 29.03.26

Sell mit Kursziel 3,0

BiotechBee 
0
Report Share
12.08.24
In the thread Trading Verrica Pharmaceuticals
Prediction Sell
Perf. (%) 21.53%
Target price 3.000
Change
Ends at 29.03.26

Sell beendet

BiotechBee 
0
Report Share
14.08.24